1) La descarga del recurso depende de la página de origen
2) Para poder descargar el recurso, es necesario ser usuario registrado en Universia


Opción 1: Descargar recurso

Detalles del recurso

Descripción

BACKGROUND: In many randomized controlled trials, patients and doctors are more interested in the per-protocol effect than in the intention-to-treat effect. However, valid estimation of the per-protocol effect generally requires adjustment for prognostic factors associated with adherence. These adherence adjustments have been strongly questioned in the clinical trials community, especially after 1980 when the Coronary Drug Project team found that adherers to placebo had lower 5-year mortality than non-adherers to placebo. METHODS: We replicated the original Coronary Drug Project findings from 1980 and re-analyzed the Coronary Drug Project data using technical and conceptual developments that have become established since 1980. Specifically, we used logistic models for binary outcomes, decoupled the definition of adherence from loss to follow-up, and adjusted for pre-randomization covariates via standardization and for post-randomization covariates via inverse probability weighting. RESULTS: The original Coronary Drug Project analysis reported a difference in 5-year mortality between adherers and non-adherers in the placebo arm of 9.4 percentage points. Using modern approaches, we found that this difference was reduced to 2.5 (95% confidence interval: -2.1 to 7.0). CONCLUSION: Valid estimation of per-protocol effects may be possible in randomized clinical trials when analysts use appropriate methods to adjust for post-randomization variables.

Pertenece a

Digital Access to Scholarship at Harvard  

Autor(es)

Murray, Eleanor Jane -  Hernan, Miguel Angel - 

Id.: 70870800

Idioma: inglés (Estados Unidos)  - 

Versión: 1.0

Estado: Final

Palabras claveCoronary Drug Project - 

Tipo de recurso: Journal Article  - 

Tipo de Interactividad: Expositivo

Nivel de Interactividad: muy bajo

Audiencia: Estudiante  -  Profesor  -  Autor  - 

Estructura: Atomic

Coste: no

Copyright: sí

: open

Requerimientos técnicos:  Browser: Any - 

Relación: [References] 10.1177/1740774516634335
[References] https://www.ncbi.nlm.nih.gov/pubmed/26951361
[References] Clinical Trials: Journal of the Society for Clinical Trials

Fecha de contribución: 13-ene-2018

Contacto:

Localización:
* Quick submit: 2018-01-04T20:22:00-0500
* Murray, Eleanor J, and Miguel A Hernán. 2016. “Adherence Adjustment in the Coronary Drug Project: A Call for Better Per-Protocol Effect Estimates in Randomized Trials.” Clinical Trials: Journal of the Society for Clinical Trials 13 (4) (March 7): 372–378. doi:10.1177/1740774516634335.
* 1740-7745
* 0000-0003-0043-4901

Otros recursos del mismo autor(es)

  1. Infective endocarditis and cancer in the elderly
  2. Using Observational Data to Calibrate Simulation Models BACKGROUND: Individual-level simulation models are valuable tools for comparing the impact of clinic...
  3. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions Non-randomised studies of the effects of interventions are critical to many areas of healthcare eval...
  4. Infective endocarditis and cancer in the elderly Little is known about the magnitude of the association between infective endocarditis and cancer, an...
  5. Methods to Estimate the Comparative Effectiveness of Clinical Strategies that Administer the Same Intervention at Different Times Clinical guidelines that rely on observational data due to the absence of data from randomized trial...

Otros recursos de la mismacolección

  1. Attitudes to Mesalamine Questionnaire: A Novel Tool to Predict Mesalamine Nonadherence in Patients with IBD OBJECTIVES: Poor adherence to mesalamine is common and driven by a combination of lifestyle and beha...
  2. Computer Model Challenges Breast Cancer Treatment Strategy The breast cancer treatment failure rate remains unacceptably high. The current breast cancer treatm...
  3. Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission Dysregulated immune responses to gut microbes are central to inflammatory bowel disease (IBD), and g...
  4. Trends in nicotine yield in smoke and its relationship with design characteristics among popular U.S. cigarette brands, 1997-2005 Objectives: To determine whether nicotine yields in the smoke of cigarettes would show an overall in...
  5. Is there a rationale for an anesthesiologist's role against cancer recurrence? Growth of tumors can accelerate during the peri-operative period. Accordingly, early relapse of canc...

Aviso de cookies: Usamos cookies propias y de terceros para mejorar nuestros servicios, para análisis estadístico y para mostrarle publicidad. Si continua navegando consideramos que acepta su uso en los términos establecidos en la Política de cookies.